Dry Eye Syndrome Treatment Market - Share, Business Analysis, Explosive Growth Opportunities, Regional Analysis by Size 2020-2028
Overview:
Tears in eyes has a substantial role in lubricating the
inner process and protecting eyes from infections or any other foreign matters.
Dry eye syndrome is a disease where the lubrication process gets hindered due
to lack of tear inflow. The global Dry
Eye Syndrome Treatment Market is all ready to achieve 6.6% CAGR during the
forecast period of 2017 to 2023. Market Research Future (MRFR) identified
several growth opportunities that could trigger a positive effect.
Geriatric population, diabetes, rheumatoid arthritis, are
few of the diseases that can trigger dry eye syndrome. Better technological
installations and treatment measures can also smoothen up the growth path for
the dry eye syndrome market. However, stringent norms regarding medicine
manufacturing can deter the market growth.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/5588
Segmentation:
Type, diagnosis, treatment, distribution channel and
end-user are segments in which the global dry eye syndrome market has been
segmented by MRFR. This attempt would ensure better look into factors that can
improve the market position.
Based on the type, the dry eye syndrome market comprises
evaporative dry eye syndrome aqueous dry eye syndrome, and others.
Based on the diagnosis, the dry eye syndrome market
comprises Schirmer test, eye exam, and others. The Schirmer test is gaining
substantial acknowledgement.
Based on the treatment, the dry eye syndrome market includes
nutritional supplements, serum eye drops, lubricant eye drops,
anti-inflammatory drugs segments, surgery, and others. The lubricant eye drops
segment includes oily tear eye drops, ointments, preservative-free drops, and
others. The anti-inflammatory drugs segment encompasses tetracyclines,
corticosteroids, and others. The surgery segment has punctal occlusion, intense
pulsed light therapy, and others under its purview.
Based on the distribution channel, the dry eye syndrome
market consists online pharmacies, retail pharmacies, hospital pharmacies, and
others. The retail pharmacies are doing good, however, the online pharmacies
can gain more, if they clear stringent government policies.
Based on the end-users, the dry eye syndrome market includes
hospitals, clinics, home care, and others.
Regional Analysis:
The Americas, Europe, Asia Pacific (APAC), and the Middle
East & Africa (MEA) are segments that can be assessed to understand a
proper functioning of the global dry eye syndrome market. This market
segmentation includes a detailed study of various growth pockets, which can be
taken into consideration to chart the progress route.
The Americas has significant market dominance and this is
due to better diagnosis, infrastructural strength, high expenditure, and easy
reimbursement policies. The presence of the US, and Canada are also expected to
fetch in revenues. Cuba is also doing great in South America, along with Brazil
and Argentina. The presence of several titans like Auven therapeutics, Johnson
& Johnson Vision, Acadia Pharmaceutical, and others is also adding fuel to
the market growth.
Europe has the second largest market and is getting
benefitted from the high patient population. Healthcare sector in the region is
quite robust and has a name for receiving remarkable funds from governments and
private organizations. The APAC market is emerging as a market with high
potential where India, China, Australia, and others are performing well. All
these regions are expecting high CAGR during the forecast period.
Access Report Details @ https://www.marketresearchfuture.com/reports/dry-eye-syndrome-market-5588
Competitive Landscape:
Various pharmaceuticals are impacting the global dry eye
syndrome market by improving the competition in the market with strategic
inclusions of processes like merger, acquisition, collaboration, and other
methods. The global market is also gaining from such prolific moves. MRFR
listed a few in their global dry eye syndrome market report and profiled them
to get a hand over latest trends that could impact the market in the future.
These companies are Novartis AG (Switzerland), Allergan (Republic of Ireland),
Valent Pharmaceuticals (Canada), Otsuka Pharmaceutical Co. Ltd. (Japan), Acadia
Pharmaceutical (U.S.), Johnson and Johnson Vision (U.S.), I-Med Pharma Inc.
(Canada), Allostera Pharma (Canada), AFT pharmaceuticals (New Zealand), Santen
Pharmaceuticals Co. Ltd., (Japan), Auven therapeutics (U.S.), Novaliq GmBh
(Germany), and others.
·
In August 2019, results from phase 2 and 3 of
the ribonucleic acid (siRNA) inhibitor tivanisiran delivered positive outcomes
as a cure for dry eye syndrome. The test is getting done by researchers from
Sylentis and it has been conducted in six countries. The result shows a stark
improvement in the condition.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by
Components, Application, Logistics and market players for global, regional, and
country level market segments, enable our clients to see more, know more, and
do more, which help to answer all their most important questions.
Contact:
Market Research Future®
99 Hudson Street,5Th Floor
New York, New York 10013
United States of America
Phone:
+1 628 258 0071(US)
+44 2035 002 764(UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
Comments
Post a Comment